JENNIFER STUTTS: Open Payments
NPI 1881084192 · ROCK HILL, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$935 in 76 payments from 10 companies in 2025. Trend: 2023 $1,662 · 2024 $1,355 · 2025 $935
Food & beverage: $935
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $444 |
| Neurocrine BioSciences, Inc. | 17 | $255 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $85 |
| Vanda Pharmaceuticals Inc. | 2 | $30 |
| HARMONY BIOSCIENCES LLC | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $15 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
| Neos Therapeutics, LP | 1 | $14 |
Products named: VRAYLAR, INGREZZA, TRINTELLIX, REXULTI, HETLIOZ, WAKIX, Auvelity, INVEGA SUSTENNA.
Industry payments across SC — which companies pay providers there.
